Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Terminated 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2

Conditions

Leiomyoma 13Anemia 2Fibroma 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Epoetin Alfa 7Darbepoetin alfa 6epoetin beta 4Lenalidomide 4Cyclophosphamide 4ACE-011 4fludarabine 3Busulfan 3thymoglobulin 2telapristone acetate 2luspatercept 2fludarabine phosphate 2Cyclosporine 2Antilymphocyte Serum 2AP 1903 reagent 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2vactosertib 1ruxolitinib 1roxadustat 1obinutuzumab 1ibrutinib 1fosphenytoin 1ferrous sulfate 1ferric gluconate 1ferric carboxymaltose 1eltrombopag 1angiotensin I (1-7) 1Whole-Body Irradiation 1Thiotepa 1Therapeutics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Anemia × telapristone acetate × Clear all
NCT00702702 2014-08-21

Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids

Repros Therapeutics Inc.

Phase 3 Terminated
56 enrolled 1 chart
Classical hematology

Anemia, Leiomyoma

NCT00785356 2014-08-21

Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids

Repros Therapeutics Inc.

Phase 3 Terminated
8 enrolled 1 chart
Classical hematology

Anemia, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡